-
Gift accelerates new treatment possibilities for neuroendocrine tumors
An anonymous donor first became acquainted with Dana-Farber Cancer Institute in 2021 through their desire to support the fundraising efforts of a friend
-
Oetgen Family invests in early detection and intervention for myeloma
Dana-Farber has launched a revolution in myeloma care, thanks to the power of precision medicine, genomics, immunotherapy, and philanthropy.
-
Defeating advanced and aggressive kidney cancers
The Kidney Cancer Association (KCA) has made $650,000 in grants to three Dana-Farber researchers who are unlocking the molecular mechanisms of a disease that will be diagnosed in nearly 82,000 U.S. residents this year and claim the lives of more than 14,000.
-
The Dana-Farber Campaign
Establishing an endowment is a powerful way to support The Dana-Farber Campaign.
-
Emerald Foundation, Inc.
Emerald Foundation, Inc., awarded $300,000 to support research harnessing natural killer (NK) cells for use in immunotherapies. NK cells play a major role in the elimination of both tumors and infected cells, and this research will provide valuable insight that will inform better treatment strategies.
-
Richard and Eileen Greisch
Richard and Eileen Greisch made a gift of $100,000 to provide essential resources for melanoma research under the direction of Tamara Sussman, MD. These funds will enable researchers to test novel therapeutics in clinical trials, lead investigations in genomic sequencing, and develop groundbreaking immunotherapeutic approaches.
-
Dana-Farber joins with Parker Institute for Cancer Immunotherapy to accelerate cures for the world’s gravest cancers
Dana-Farber has partnered with the Parker Institute for Cancer Immunotherapy (PICI), the leading network of immuno-oncology expertise in the world, as a member of the PICI Network with a goal of better understanding the tumor microenvironment across cancer types and translating these basic discoveries into impactful cancer immunotherapies for patients.
-
Cancer Research Institute invests in the people behind basic research discoveries in cancer immunology
While the immune system is inherently able to identify and destroy harmful cells, tumors often develop ways to interrupt anti-cancer immune activity. Restoring this powerful effect in order to defeat cancer through therapies that galvanize the immune system has transformed the treatment trajectory and potential for cure in many cancers.
-
IMS grants drive innovative multiple myeloma research
The International Myeloma Society (IMS) recently awarded three Dana-Farber scientists grants totaling $525,000 to promote research on the blood cancer multiple myeloma.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.